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The anaerobic actinobacterium Gardnerella was ﬁrst isolated from the bladder by
suprapubic aspiration more than 50 years ago. Since then, Gardnerella has been
increasingly recognized as a common and often abundant member of the female
urinary microbiome (urobiome). Some studies even suggest that the presence of
Gardnerella is associated with urological disorders in women. We recently reported that
inoculation of Gardnerella into the bladders of mice results in urothelial exfoliation. Here,
we performed whole bladder RNA-seq in our mouse model to identify additional host
pathways involved in the response to Gardnerella bladder exposure. The transcriptional
response to Gardnerella reﬂected the urothelial turnover that is a consequence of
exfoliation while also illustrating the activation of pathways involved in inﬂammation and
immunity. Additional timed exposure experiments in mice provided further evidence of a
potentially clinically relevant consequence of bladder exposure to Gardnerella—increased
susceptibility to subsequent UTI caused by uropathogenic Escherichia coli. Together,
these data provide a broader picture of the bladder’s response to Gardnerella and lay the
groundwork for future studies examining the impact of Gardnerella on bladder health.
Keywords: urobiome, bladder, dysbiosis, urothelium, bacterial vaginosis, urinary tract infection, RNA-seq

INTRODUCTION
Gardnerella comprises a genus of Gram-variable Actinobacteria that are frequently present in the
microbiota of the female urogenital system. Gardnerella vaginalis has historically been regarded as a
vaginal organism because it was ﬁrst identiﬁed in vaginal ﬂuid, where it was implicated as the
causative agent in the prevalent condition clinically recognized as bacterial vaginosis (BV) (Leopold,
1953; Gardner and Dukes, 1954; Schwebke et al., 2014; Morrill et al., 2020). BV is a state of the
vaginal microbiome that is composed of a polymicrobial mixture of anaerobic bacteria. Further
studies over the past 50 years have revealed that G. vaginalis is frequently found among the vaginal
microbiota outside the context of symptomatic BV (Krohn et al., 1989; Briselden and Hillier, 1990).
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developed a mouse model of Gardnerella bladder exposure
(Gilbert et al., 1986; O'Brien et al., 2020). We refer to this model
as an “exposure” rather than an infection because Gardnerella is
cleared from the urinary tract within 12 h. Even such a transient
presence of Gardnerella in the urinary tract was sufﬁcient to trigger
apoptosis and exfoliation of the superﬁcial bladder epithelial
(urothelial) cells (Gilbert et al., 2017). Exfoliation is an innate
host response known to occur during symptomatic UTI that is
presumably aimed at helping eliminate bacteria from the bladder
via shedding of infected epithelial cells (Mysorekar and Hultgren,
2006; Lin et al., 2015). Here, we further probed the host response
to Gardnerella in the urinary tract by examining the bladder
transcriptome using RNA-seq. Two successive exposures to
Gardnerella activated genes and pathways in the bladder that are
related to DNA damage, programmed cell death, cell
differentiation, and proliferation, which are consistent with the
processes of urothelial exfoliation and renewal. Additionally,
Gardnerella exposure inﬂuenced gene sets related to immune
and inﬂammatory responses. Finally, we demonstrate that
preexposure to Gardnerella resulted in heightened bacterial
loads upon subsequent uropathogenic Escherichia coli (UPEC)
experimental UTI, promoting persistent UPEC bacteriuria and
increased bladder tissue titers. These ﬁndings provide proof of
concept that even transient Gardnerella bladder exposures affect
the bladder mucosa in ways that can alter the course of
UPEC UTI.

However, even in asymptomatic women, Gardnerella is more
frequently present and is often the predominant organism in the
context of a vaginal “community state type” (CST) that is
composed of a polymicrobial mixture of anaerobic bacteria
(Ravel et al., 2011). G. vaginalis has a complicated taxonomic
history, originally being named Haemophilus vaginalis and then
Corynebacterium vaginale (Gardner and Dukes, 1955;
Zinnemann and Turner, 1963). Most recently, a split of the
Gardnerella genus into 13 distinct species has been proposed
(Vaneechoutte et al., 2019). Some strains that have been
characterized and previously referred to in the literature as G.
vaginalis would fall into a different species with the newly
proposed nomenclature, including the strain we used in this
study. For ease of understanding, here, we primarily use only the
genus name Gardnerella.
Urine is the second most common source of isolation of
Gardnerella, after the vagina. Gardnerella is a rare cause of
symptomatic urinary tract infection (UTI), and it is more often
detected in urine samples collected in studies aimed at proﬁling
the composition of the urinary microbiome, or “urobiome”
(Kline and Lewis, 2016). In the ﬁrst report of isolation from
the bladder in 1968, Gardnerella was cultured from 159/1000
suprapubic aspirates from healthy pregnant women (Mcfadyen
and Eykyn, 1968). Subsequent culture-based studies isolated
Gardnerella in bladder aspirates from women with and without
current or prior urinary tract diseases (Birch et al., 1981;
McDowall et al., 1981; McDonald et al., 1982; Fairley and
Birch, 1983; Gilbert et al., 1986). In studies using modern 16S
sequencing and expanded quantitative culture methods,
Gardnerella has emerged as one of the most frequently isolated
members of the female urobiome and is the dominant organism
in many women (Hilt et al., 2014; Pearce et al., 2014; Pearce et al.
2015; Gottschick et al., 2017; Jacobs et al., 2017; Price et al.,
2020). Like Gardnerella, a majority of other urobiome bacteria
are members of genera historically regarded as vaginal
organisms, such as Lactobacillus. Recent studies have found
substantial overlap between the urinary and vaginal
microbiomes present concurrently in the same woman
(Komesu et al., 2019; Brown et al., 2021; Hugenholtz et al.,
2022). Although the presence of Gardnerella in urine specimens
could reﬂect periurethral or vaginal colonization, the fact that
many studies have cultured Gardnerella from urine collected
directly from the bladder by suprapubic aspiration or
catheterization strongly suggests that Gardnerella gains access
to the bladder, at least transiently, in some women.
Whether, or how, urobiome members such as Gardnerella
stably colonize the bladder remains to be determined. We also
know very little regarding how the bladder responds to bacterial
exposures outside of the context of symptomatic UTI. This is
important because there has been growing interest in the concept
of manipulating the urobiome as a therapeutic strategy for a wide
range of lower urinary tract conditions (Jung and Brubaker, 2019;
Cole et al., 2021; Jones et al., 2021; Garofalo et al., 2022). Mouse
models have proven valuable in advancing our understanding of
bladder responses to established uropathogens, but animal models
examining common urobiome bacteria are limited. We previously
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RESULTS
Effect of Gardnerella Exposures on the
Bladder Transcriptome
We performed RNA-seq on whole bladders to identify host
responses to Gardnerella exposures in naive mice. Figure 1A
summarizes the experimental timeline. Our previous
experiments demonstrated that Gardnerella is cleared from the
mouse bladder within 12 h and that two exposures are required
to elicit urothelial exfoliation (Gilbert et al., 1986). Presently, ﬁve
female C57BL/6 mice were inoculated twice intravesically with
Gardnerella strain JCP8151B. Four age-matched female C57BL/6
mice were inoculated twice with PBS in parallel (PBS) to serve as
controls. Exposures were given 12 h apart, and bladders were
collected 12 h after the second exposure.
RNA was extracted individually from each bladder and used
for RNA-seq. A total of 305,893,605 RNA-seq reads were
generated. Of these, 207,076,414 unique reads could be aligned
to the Mus musculus reference genome. Further details of the
RNA-seq reads are found in Supplementary Table S1.
Differentially expressed genes (FDR adjusted p < 0.05,
log2FC > 2) and pathways were identiﬁed by comparing
bladders in the Gardnerella group to PBS controls. At the
individual gene level, Gardnerella exposure resulted in
signiﬁcantly increased expression of 38 genes and decreased
expression of 11 genes relative to PBS controls (Figure 1B;
Table 1). Gene set enrichment analyses, using both the Gene
Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes
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A

B

FIGURE 1 | Gardnerella exposures alter the bladder transcriptome. (A) Schematic of the urinary tract exposure model used for RNA-seq. Female C57BL/6 mice were
given intravesical “urinary tract exposures” of either PBS or Gardnerella via transurethral catheterization. Each mouse received two exposures that were administered
12 h apart. Bladders were collected 12 h after the second exposure and processed for RNA-seq. Gardnerella-exposed bladders were compared to PBS-exposed
control bladders to identify differentially expressed genes and for gene set enrichment analyses. (B) MA-plot indicates genes that had altered expression in Gardnerella
compared to PBS bladders. Red dots denote genes that were signiﬁcantly differentially expressed after false discovery rate (FDR) correction for multiple comparisons.
Genes discussed in the text are indicated by name.

the rest of the enriched GO biological process terms; 49 were
related to immune and inﬂammatory processes involving
cytokines, chemokines, and leukocytes (Supplementary Table
S2), and 15 were relevant “response to…” and “defense response
to…” terms such as “bacterium,” “molecule of bacterial origin,”
“external biotic stimulus,” and “other organism”
(Supplementary Table S2). Activation of host inﬂammatory
responses was also reﬂected in the upregulated GO molecular
functions, with top hits indicating cytokine and chemokine
activity and chemokine receptor binding (Figure 2B). Likewise,
“cytokine–cytokine receptor interactions” and “chemokine
signaling pathway” were among the upregulated KEGG
pathways, as well as the HIF-1a signaling pathway that is
known to mediate the host inﬂammatory response to bacteria
(Figure 2C). Among the individual upregulated genes (Table 1)
were the inﬂammatory mediator Cxcl5 and its cognate receptor
Cxcr2, the antimicrobial peptide Ptx3, the innate immune cell
activating lectin Clec4e (also known as Mincle), and Trem1,
which is expressed on myeloid cells and stimulates release of
inﬂammatory cytokines in response to pathogens (Tessarz and
Cerwenka, 2008). Given the gene expression signature of
inﬂammation, we examined whether Gardnerella-exposed
bladders collected at the same time point used for RNA-seq
analysis displayed robust neutrophil migration into the
urothelium like what has been seen during bladder infection
with established uropathogens (Mulvey et al., 2000; Mulvey et al.,
2001). However, we did not observe robust neutrophil
inﬁltration into the urothelium in any of the Gardnerellaexposed bladders (Supplementary Figure S1), suggesting that
either more time or additional exposures may be required to
effect changes at the level of neutrophil recruitment, or that a
different cellular response occurs. Future time-course

(KEGG) pathway databases, were performed on the full RNAseq dataset to gain a broader perspective of the biological effects
of Gardnerella exposures on the bladder (Figure 2). The GO
term analyses detected signiﬁcant enrichment (p < 0.05,
log2FC > 2) of 153 GO biological processes and 16 GO
molecular functions (Supplementary Tables S2, S3) in
Gardnerella bladders compared to PBS. Sixteen KEGG
pathways were signiﬁcantly enriched (p < 0.05, log2FC > 2)
(Supplementary Table S4). There were very few signiﬁcantly deenriched pathways across all three categories; only the GO
molecular function “pheromone activity” and the “steroid
hormone biosynthesis” KEGG pathway were moderately
decreased. In addition to single direction changes (all genes in
the pathway either went UP or DOWN), seven KEGG pathways
were signiﬁcantly dysregulated in ANY direction (some genes in
the same pathway went up and others went down)
(Supplementary Table S4). As a whole, the RNA-seq data
pointed to two broad categories affected by Gardnerella
exposure: (1) inﬂammation and immune response and (2)
urothelial exfoliation and differentiation.

Inﬂammatory Pathways Are Upregulated
After Gardnerella Exposures
As would be expected in a bacterial exposure model, most of the
gene sets enriched in Gardnerella-exposed bladders were related
to inﬂammatory responses. We previously reported higher levels
of bladder IL-12p40 following Gardnerella exposure (Gilbert et
al., 2017). The most highly upregulated GO biological processes
(Figure 2A) were directly related to inﬂammation, including
leukocyte migration and chemotaxis (dark blue dots) or the more
general “response to…” terms such as “bacterium” or “external
biotic stimulus” (light blue dots). This theme continued through
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TABLE 1 | Genes differentially expressed in the bladder after two Gardnerella exposures.
Gene name
Cxcl5
Trem1
Syngr4
Clec4e
Krt6a
1810065E05Rik
Ptpn5
Anxa10
Bdkrb1
Chrnb4
Fmo4
Sprr2g
Fosl1
Vat1l
Tff1
Ptx3
Cml5
Cxcr2
Pinlyp
Fam3b
Mefv
Gjb4
Csta1
Tnfaip6
Qrfpr
Gm10309
Rnf183
Krt13
Serpina3m
Mmp10
Ch25h
Socs3
Usp2
Timp1
Lonrf3
Nts
Nr4a2
Errﬁ1
Nr1d1
2310015D24Rik
Egr1
Snora31
Gm15883
Gm12426
Fos
1200007C13Rik
Gm26887
Gm5828
Igkv12-46

Description

logFC

p-value

FDR

Chemokine (C-X-C motif) ligand 5 [Source : MGI Symbol;Acc : MGI:1096868]
Triggering receptor expressed on myeloid cells 1 [Source : MGI Symbol;Acc : MGI:1930005]
Synaptogyrin 4 [Source : MGI Symbol;Acc : MGI:1928903]
C-type lectin domain family 4, member e [Source: MGI Symbol;Acc : MGI:1861232]
Keratin 6A [Source : MGI Symbol;Acc : MGI:1100845]
RIKEN cDNA 1810065E05 gene [Source : MGI Symbol;Acc : MGI:1917114]
Protein tyrosine phosphatase, non-receptor type 5 [Source : MGI Symbol;Acc : MGI:97807]
Annexin A10 [Source : MGI Symbol;Acc : MGI:1347090]
Bradykinin receptor, beta 1 [Source : MGI Symbol;Acc : MGI:88144]
Cholinergic receptor, nicotinic, beta polypeptide 4 [Source : MGI Symbol;Acc : MGI:87892]
Flavin containing monooxygenase 4 [Source : MGI Symbol;Acc : MGI:2429497]
Small proline-rich protein 2G [Source : MGI Symbol;Acc : MGI:1330348]
Fos-like antigen 1 [Source : MGI Symbol;Acc : MGI:107179]
Vesicle amine transport protein 1 homolog-like (T. californica) [Source : MGI Symbol;Acc : MGI:2142534]
trefoil factor 1 [Source : MGI Symbol;Acc : MGI:88135]
Pentraxin-related gene [Source : MGI Symbol;Acc : MGI:104641]
Camello-like 5 [Source : MGI Symbol;Acc : MGI:1916299]
Chemokine (C-X-C motif) receptor 2 [Source : MGI Symbol;Acc : MGI:105303]
Phospholipase A2 inhibitor and LY6/PLAUR domain containing [Source : MGI Symbol;Acc : MGI:3615324]
Family with sequence similarity 3, member B [Source : MGI Symbol;Acc : MGI:1270150]
Mediterranean fever [Source : MGI Symbol;Acc : MGI:1859396]
Gap junction protein, beta 4 [Source : MGI Symbol;Acc : MGI:95722]
Cystatin A1 [Source : MGI Symbol;Acc : MGI:3524930]
Tumor necrosis factor alpha induced protein 6 [Source : MGI Symbol;Acc : MGI:1195266]
Pyroglutamylated RFamide peptide receptor [Source : MGI Symbol;Acc : MGI:2677633]
Predicted gene 10309 [Source : MGI Symbol;Acc : MGI:3641941]
Ring ﬁnger protein 183 [Source : MGI Symbol;Acc : MGI:1923322]
Keratin 13 [Source : MGI Symbol;Acc : MGI:101925]
Serine (or cysteine) peptidase inhibitor, clade A, member 3M [Source : MGI Symbol;Acc : MGI:98378]
Matrix metallopeptidase 10 [Source : MGI Symbol;Acc : MGI:97007]
Cholesterol 25-hydroxylase [Source : MGI Symbol;Acc : MGI:1333869]
Suppressor of cytokine signaling 3 [Source : MGI Symbol;Acc : MGI:1201791]
Ubiquitin speciﬁc peptidase 2 [Source : MGI Symbol;Acc : MGI:1858178]
Tissue inhibitor of metalloproteinase 1 [Source : MGI Symbol;Acc : MGI:98752]
LON peptidase N-terminal domain and ring ﬁnger 3 [Source : MGI Symbol;Acc : MGI:1921615]
neurotensin [Source : MGI Symbol;Acc : MGI:1328351]
Nuclear receptor subfamily 4, group A, member 2 [Source : MGI Symbol;Acc : MGI:1352456]
ERBB receptor feedback inhibitor 1 [Source : MGI Symbol;Acc : MGI:1921405]
Nuclear receptor subfamily 1, group D, member 1 [Source : MGI Symbol;Acc : MGI:2444210]
RIKEN cDNA 2310015D24 gene [Source : MGI Symbol;Acc : MGI:1917350]
early growth response 1 [Source : MGI Symbol;Acc : MGI:95295]
Small nucleolar RNA, H/ACA box 31 [Source : MGI Symbol;Acc : MGI:3819500]
Predicted gene 15883 [Source : MGI Symbol;Acc : MGI:3801875]
Predicted gene 12426 [Source : MGI Symbol;Acc : MGI:3650989]
FBJ osteosarcoma oncogene [Source : MGI Symbol;Acc : MGI:95574]
RIKEN cDNA 1200007C13 gene [Source : MGI Symbol;Acc : MGI:1921369]
Predicted gene, 26887 [Source : MGI Symbol;Acc : MGI:5477381]
Predicted gene 5828 [Source : MGI Symbol;Acc : MGI:3644176]
Immunoglobulin kappa variable 12-46 [Source : MGI Symbol;Acc : MGI:4439773]

8.11756
6.00981
5.43623
5.23586
4.81622
4.72987
4.5585
4.14225
4.03099
3.95127
3.42047
3.40759
3.27974
3.13659
3.1289
3.07996
3.06793
3.02361
3.00226
2.97956
2.97595
2.93731
2.91392
2.85446
2.84716
2.82107
2.76461
2.64816
2.53427
2.5287
2.49894
2.46996
2.41504
2.22733
2.20086
2.10926
2.10351
2.05576
−2.14917
−2.18627
−2.28215
−2.31741
−2.73333
−3.28567
−3.8295
−3.85771
−4.04586
−4.35603
−7.10718

3.07E−07
1.85E−05
3.22E−05
3.63E−07
2.32E−06
2.13E−05
1.09E−04
6.77E−08
1.47E−07
1.23E−04
4.32E−05
7.56E−07
7.83E−07
1.53E−04
2.34E−05
2.16E−05
3.25E−06
2.04E−06
5.61E−05
1.23E−06
3.87E−05
4.19E−05
6.98E−09
2.18E−07
1.08E−05
1.25E−04
8.21E−06
6.48E−05
3.16E−06
1.30E−04
1.77E−06
1.02E−04
4.93E−10
5.90E−06
1.56E−05
1.30E−04
3.39E−08
3.84E−09
1.41E−13
9.74E−05
2.16E−09
6.27E−06
1.61E−04
9.06E−05
2.01E−17
8.66E−05
1.78E−05
8.69E−05
3.20E−06

4.98E−04
1.09E−02
1.54E−02
5.64E−04
2.51E−03
1.19E−02
3.77E−02
1.42E−04
2.76E−04
4.11E−02
1.88E−02
1.04E−03
1.04E−03
4.75E−02
1.25E−02
1.19E−02
3.23E−03
2.35E−03
2.33E−02
1.56E−03
1.75E−02
1.85E−02
2.08E−05
3.81E−04
6.92E−03
4.12E−02
5.98E−03
2.63E−02
3.23E−03
4.21E−02
2.15E−03
3.57E−02
2.94E−06
4.79E−03
9.61E−03
4.21E−02
8.08E−05
1.25E−05
2.52E−09
3.50E−02
7.72E−06
4.98E−03
4.95E−02
3.41E−02
7.18E−13
3.37E−02
1.06E−02
3.37E−02
3.23E−03

ribosome biogenesis, translation, cell activation, and nuclear
division (Supplementary Tables S2–S4). The “neuroactive
ligand–receptor interaction,” “cytokine–cytokine receptor
interaction,” and “retinol metabolism” (Lu et al., 2021) KEGG
pathways have been linked to bladder cancer (Zhang et al., 2021).
Several of the individual genes upregulated by Gardnerella
exposures are involved in epithelial to mesenchymal transition
(Cxcl5, Cxcr2, Tff1) (Lee et al., 2021) or known to be elevated
during squamous metaplasia or bladder cancer (Anxa10, Fosl1,
Krt6a, Mmp10) (Cao et al., 2010; Somji et al., 2011; Gatta et al.,
2019; Kudelski et al., 2021; Wu et al., 2021). These RNA-seq data
are consistent with our previous ﬁndings, reproduced here, that

experiments and more in-depth histological analysis by a
pathologist and assessment of speciﬁc immune cell populations
and activation states in the bladder by ﬂow cytometry are needed
to distinguish these possibilities.

Upregulated Genes and Pathways Reﬂect
Gardnerella-Induced Urothelial Exfoliation
Several signiﬁcantly upregulated gene sets were related to
urothelial integrity and turnover. ‘DNA replication’ was the
top hit in both the KEGG and GO biological process lists
(Figure 2). Additional terms indicating cell proliferation in the
Gardnerella-exposed bladders were those related to cell cycle,
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B

C

FIGURE 2 | Gene set enrichment analysis identiﬁes pathways upregulated by Gardnerella exposures. Graphs depict the top 15 gene sets from the Gene Ontology
(A, B) and KEGG (C) databases that were signiﬁcantly enriched in the bladders of mice exposed to Gardnerella relative to PBS controls.

Figure S2). Another marker of urothelial differentiation is
cytokeratin 20: its appearance on the apical membrane marks
the last event in differentiation of superﬁcial umbrella cells
(Veranic et al., 2004). Bladders from mice exposed only to PBS
had cytokeratin 20 (CK20) staining that was contiguous across
the length of the urothelial-luminal interface, indicating an intact
and fully differentiated urothelium (Figure 3B (I). In contrast,
the urothelium from mice exposed to Gardnerella had regions
lacking CK20 staining (Figure 3B (II and III). We enumerated
CK20-positive superﬁcial cells lining the urothelial surface. We

two Gardnerella exposures trigger membrane blebbing and
exfoliation of superﬁcial umbrella cells lining the bladder
lumen (Figure 3A) (Gilbert et al., 2017). To further
corroborate the RNA-seq signature of urothelial turnover,
additional bladders were examined for markers of urothelial
differentiation and proliferation. Compared to bladders exposed
only to PBS, three out of four bladders exposed to Gardnerella
displayed a noticeable increase in urothelial keratin 6 (Krt6), a
marker of squamous differentiation, which is consistent with the
increased Krt6 transcript detected by RNA-seq (Supplementary

Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

5

June 2022 | Volume 12 | Article 909799

Gilbert et al.

Outcomes of Gardnerella Bladder Exposure

D

A

E
B

F

G

C

FIGURE 3 | Gardnerella exposures result in urothelial exfoliation and proliferation. (A) Scanning electron micrographs of bladders collected 12 h after two exposures (the
model used for RNA-seq, see Figure 1 schematic) to PBS (panel I) or Gardnerella (II–IV). (I) Intact superﬁcial umbrella cells; (II) umbrella cell with membrane blebbing; (III) region
of exfoliation with smaller underlying intermediate cells visible at the luminal interface; (IV) exfoliating umbrella cell marked by an asterisk. Scale bars = 10 mm. (B)
Immunoﬂuorescence microscopy of urothelial differentiation markers in bladder sections from mice exposed to PBS (I) or Gardnerella (II and III). Keratin 5 (K5) in green labels,
basal cells; P63 in red labels, basal and intermediate cells; and cytokeratin 20 (CK20) in white labels, the apical surface of fully differentiated umbrella cells. Scale bars = 50 mm.
(C) Counts of CK20-positive (+) and CK20-negative (−) cells on the urothelial surface, adjacent to the lumen. ****p < 0.001, Fisher’s exact test. The graph was generated by
plotting the %CK20 positivity, with each dot representing an individual microscopy image of the ×20 ﬁeld of view. **p < 0.01, Mann–Whitney U test. Box plot denotes the 25th
and 75th percentiles with a line at the median and whiskers from min to max. (D) Panoramic assembly of bladder sections stained for Ki67 in red. Scale bars = 200 mm.
(E) Representative images of immunoﬂuorescence microscopy used for Ki67+ enumeration. (F, G) Tables show the counts of Ki67-positive (+) and Ki67-negative (−) cells of
superﬁcial and intermediate cells combined (F) or only superﬁcial cells (G) in each experimental group. ***p < 0.001, ****p < 0.0001, Fisher’s exact test. Graphs were generated
by plotting the %Ki67 positivity, with each dot representing an individual microscopy image as in (B). Box plot denotes the 25th and 75th percentiles with a line at the median
and whiskers from min to max.

in Gardnerella-exposed mice compared to PBS controls, we
enumerated Ki67-positive cells in the transitional urothelium
(Figures 3E–G). We also counted the total number of cells in
order to determine the percentage that were Ki67 positive. When
the transitional urothelium was analyzed (intermediate and
superﬁcial cells), the proportion of Ki67-positive cells was
signiﬁcantly higher in mice exposed to Gardnerella than in
PBS controls (Figure 3F). This increase in Ki67 positivity in
Gardnerella-exposed bladders was apparent even if only
superﬁcial cells were analyzed (Figure 3G). Our previous data
suggested that exfoliating cells are dying via apoptosis since
Gardnerella-exposed bladders exhibited increased cleaved Casp3 staining and TUNEL-positive urothelial cells (Gilbert et al.).
Consistent with this phenotypic data, Gardnerella exposures
increased 15 GO terms related to apoptosis (Supplementary
Table S2). These data, together with our previous ﬁndings,
demonstrate that bladder exposures to Gardnerella result in
urothelial exfoliation.

also counted the total number of superﬁcial cells (those at the
luminal interface) in order to determine the percentage that were
CK20 positive. These data conﬁrmed a signiﬁcant decrease in
CK20 staining in mice exposed to Gardnerella compared to PBS
controls (Figure 3C). The increased Krt6 and decreased CK20
staining pattern observed on Gardnerella-exposed bladders
suggested that exfoliation had occurred in these areas and the
urothelium had not completely healed. Finally, we examined cell
proliferation via Ki67 staining. Naive, unperturbed adult mouse
bladders have a very slow urothelial turnover and thus contain
few to no Ki67-positive cells. Exfoliation of superﬁcial urothelial
cells is known to trigger proliferation and differentiation of
underlying cells to restore the urothelium. In our model, Ki67positive cells were present in Gardnerella-exposed bladders
(Figure 3D (II), but they were also seen in bladders exposed to
PBS, reﬂecting the fact that the transurethral inoculation
procedure itself perturbs the bladder tissue (Figure 3D (I). To
determine whether there was an overall increase in proliferation
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Gardnerella Preexposures Promote Acute
UPEC Bacteriuria

The UPEC pathogenic cascade involves urothelial
attachment, invasion, and intracellular replication followed by
ﬁlamentation and egress (Klein and Hultgren, 2020). We
hypothesized that the urothelial exfoliation resulting from
Gardnerella exposure could disrupt or alter the interaction of
UPEC with the urothelium. First, we directly examined UPECbladder interactions in our preexposure model using scanning
electron microscopy (SEM). Consistent with previous reports in
naive mice, UPEC-infected mice preexposed to PBS harbored
abundant UPEC adhering to, and ﬁlamenting out of, superﬁcial
urothelial cells as well as exfoliating cells full of intracellular
bacteria (Figure 4B, top). Similar features were also seen on the
superﬁcial cells of bladders preexposed to Gardnerella
(Figure 4B, bottom), suggesting that the urothelium was still
able to harbor intracellular UPEC. One noticeable difference was
that some of the superﬁcial cells in bladders preexposed to
Gardnerella had small collections of adherent bacillary UPEC
in addition to the ﬁlamentous bacteria more typically observed in

Urothelial turnover and inﬂammatory responses in the bladder
are important features of UTI caused by established
uropathogens such as UPEC (Lacerda Mariano and Ingersoll,
2020). Given our RNA-seq results, we hypothesized that
Gardnerella exposure would affect the course of an
experimental UPEC UTI. To examine this hypothesis, we
developed a “preexposure” model in which mice received
Gardnerella exposures before UPEC inoculation (Figure 4A).
We exposed mice twice, 12 h apart, to Gardnerella as in the
RNA-seq experiment. Twelve hours after the second Gardnerella
or PBS control preexposure, mice were inoculated
transurethrally with the UPEC clinical isolate UTI89. The
UTI89 strain is widely used in experimental UTI models,
including in our prior study that reported that Gardnerella
exposures induced recurrent UPEC UTI from intraepithelial
reservoirs (Gilbert et al., 1986).

A

B

C

D

F

E

FIGURE 4 | Preexposure to Gardnerella increases acute UPEC bacteriuria and persistent infection. (A) Schematic of the mouse experiment time course. Dots on
the timeline indicate when urine was collected for CFU enumeration. Data are from ﬁve independent mouse experiments. (B) SEM images of bladders collected 6 h
after UPEC infection from mice preexposed to PBS (top) or Gardnerella (bottom). Asterisks mark exfoliating umbrella cells. Scale bars = 20 mm. Refer to
Supplementary Figure S3 for additional bladder SEM images. (C) Acute UPEC titers in urine collected 6 hpi, with each dot representing an individual mouse (107
n = 20 per group; 106 PBS n = 24, Gardnerella n = 25). *p < 0.05, Mann–Whitney U test. Box plot denotes the 25th and 75th percentiles with a line at the median
and whiskers from min to max. (D, E) Time course of UPEC bacteriuria after a 107 CFU inoculation. Red symbols indicate mice that had UPEC bacteriuria >104
CFU/ml in each weekly urine sample. (F) UPEC titers in bladder homogenates collected 28 dpi. Each dot represents an individual mouse (n = 10 per group). Red
symbols indicate mice that had UPEC bacteriuria >104 CFU/ml in each weekly urine sample. LOD, limit of detection. ***p < 0.001, Mann–Whitney U test. Box plot
denotes the 25th and 75th percentiles with a line at the median and whiskers from min to max.
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control bladders (Supplementary Figure S3, arrowheads).
Ultimately, the SEM analysis demonstrated that preexposure to
Gardnerella did not entirely disrupt the UPEC invasion and
egress cycle.
Next, we took a more quantitative approach by examining
UPEC titers in urine in our preexposure model. With an
inoculum of 107 colony-forming units (CFUs) of UPEC, which
is frequently used in mouse UTI models (Conover et al., 2015;
Gilbert et al.), UPEC urine titers were indistinguishable between
PBS preexposed and Gardnerella preexposed mice at 6 and
24 hpi (Figure 4C; Supplementary Figure S4). We reasoned
that the effects of Gardnerella might be masked in the context of
the high titer UPEC inoculum, especially at early time points.
Therefore, we also examined a lower dose of 106 CFUs of UPEC.
Strikingly, UPEC bacteriuria was signiﬁcantly higher at 6 hpi in
mice preexposed to Gardnerella than in PBS preexposed controls
(Figure 4C). These data suggest that alterations in the bladder
niche caused by preexposures to Gardnerella promote
UPEC bacteriuria.

tissues in the absence of bacteriuria has previously been shown to
reside in quiescent intracellular reservoirs (Mulvey et al., 2001),
suggesting that preexposure to Gardnerella may promote the
formation of more, or larger, reservoirs. Future studies using
methods that distinguish intracellular from luminal UPEC are
needed to distinguish these possibilities. Taken together, these
initial studies demonstrate that preexposure to Gardnerella
promotes both acute and persistent UPEC infection in
the bladder.

DISCUSSION
Gardnerella is a common, and often dominant, member of the
vaginal microbiome, especially in the context of dysbiosis
(Morrill et al., 2020). Likewise, Gardnerella has recently been
recognized as a frequent, dominant member of the urobiome,
including in studies that used collection methods to limit
contamination by periurethral or vaginal organisms (Birch
et al., 1981; McDowall et al., 1981; McDonald et al., 1982;
Fairley and Birch, 1983; Gilbert et al., 1986). Despite
Gardnerella being frequently isolated from urine, relatively
little is known regarding the biological effects of Gardnerella
on bladder tissue. To address this lack of knowledge, we recently
developed a model of Gardnerella bladder exposure in female
mice (O'Brien et al., 2020). Here, we further characterized our
model using whole bladder RNA-seq to determine the bladder
transcriptomic response to Gardnerella. The RNA-seq data,
along with additional microscopy validation studies, echo our
previous report of Gardnerella-induced urothelial apoptosis and
exfoliation (Gilbert et al., 2017). The RNA-seq results further
revealed that Gardnerella activates host transcriptional pathways
related to mucosal inﬂammation and immunity. Taken together,
these data provide evidence that bacterial species such as
Gardnerella, that have been frequently identiﬁed in urinary
microbiome studies but have remained understudied, have
observable biological effects on the bladder tissue in a relevant
in vivo model.
To further explore the potential clinical relevance of
Gardnerella bladder exposures, here, we focused on the effect
of Gardnerella on UTIs caused by UPEC. We chose to focus ﬁrst
on UPEC UTI for the following reasons: First, women with BV,
who thus have high levels of Gardnerella, are at increased risk of
UTI (Hooton et al., 1989; Sumati and Saritha, 2009; Hillebrand
et al., 2022). Second, sexual activity, which likely results in
bladder exposure to urogenital bacteria like Gardnerella, is one
of the strongest risk factors for UTI (Nicolle et al., 1982; Foxman,
2014). Of particular relevance to these ﬁrst two points, one study
found that the strongest correlation between the vaginal and
urinary microbiome occurred in women with BV (Gottschick
et al.). Third, modulation of the urobiome has been proposed as
an antibiotic-sparing alternative therapeutic approach to treat or
prevent UTIs (Jung and Brubaker, 2019; Cole et al., 2021; Jones
et al., 2021; Garofalo et al., 2022), but the direct impact of
urobiome members on UTI outcomes have not been examined in
vivo. Fourth, the most notable effects of Gardnerella in our RNA-

Gardnerella Exposures Promote UPEC
Persistence in the Bladder
Since we observed an effect of Gardnerella preexposures on acute
bacteriuria, we examined whether this would extend to later time
points and whether the effect would be observable in bladder tissue
in addition to urine. Wild-type C57BL/6 female mice are generally
not susceptible to persistent (chronic) bacteriuria following a single
UPEC inoculation (Schwartz et al., 2015). Consistent with prior
reports, most of the mice inoculated with 106 CFUs of UPEC
cleared bacteriuria by 24 hpi, with no apparent difference between
preexposure groups (Supplementary Figure S4). With an inoculum
of 107 CFUs of UPEC, only 10% of mice in the PBS control
preexposure group had UPEC bacteriuria that persisted at >104
CFU/ml out to 4 weeks postinfection (wpi) (Figure 4D), compared
with 50% in mice preexposed to Gardnerella (Figure 4E). Previous
studies have shown that mice that develop persistent bacteriuria
have higher levels of the proinﬂammatory cytokines IL-5, IL-6, KC,
and G-CSF in serum at 24 hpi compared to those that ultimately
clear the infection (Hannan et al., 2010; Schwartz et al., 2015). We
hypothesized that Gardnerella exposure alone may result in a
similar cytokine signature, and if this were to occur prior to
UPEC introduction into the bladder, it could prime the host for
the development of persistent UPEC infection. To test this
hypothesis, we measured cytokine levels in bladders that were
exposed twice to Gardnerella and were collected at the time point
that they would have received UPEC in our preexposure model.
However, inconsistent with our hypothesis, there was no difference
in serum levels of IL-5, IL-6, KC, or G-CSF (Supplementary Figure
S5) or in any of the other 23 cytokines/chemokines measured (data
not shown) in mice preexposed to Gardnerella versus to PBS.
Bladder titers of UPEC at 4 wpi were signiﬁcantly higher in
mice exposed to Gardnerella compared to PBS controls
(p = 0.0003; Figure 4F). This difference remained signiﬁcant
even when the bladders from mice without persistent UPEC
bacteriuria were analyzed separately (Supplementary Figure
S6). This is notable because UPEC that is detectable in bladder
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speciﬁc regions or cell types of the bladder, and RNA-seq
analysis will not uncover epigenetic changes that have
occurred. Another limitation was that we only examined one
strain of Gardnerella (JCP8151B) that is a vaginal isolate and
which may become reclassiﬁed as a species other than vaginalis
(but was regarded as G. vaginalis when we performed our study).
Studies examining associations between Gardnerella in the
urobiome and various conditions associated with lower urinary
tract symptoms, such as urgency urinary incontinence and
overactive bladder, have yielded mixed results. However, many
of these studies only examined the urobiome at the genus level
and did not distinguish between Gardnerella species or
subgroups. It is possible that the inconsistency in associations
with lower urinary tract symptoms reﬂects that different
Gardnerella species have greater or less capacity to inﬂuence
the bladder. It has been noted that G. piotii has not yet been
isolated from urine, while most other species and subspecies of
Gardnerella have been isolated from both niches (Putonti et al.,
2021). However, this could be attributed to differences in the
culture techniques that were used in studies isolating Gardnerella
from the urine compared to those that isolated Gardnerella from
the vagina. Whether or not different Gardnerella species or
subgroups display different colonization kinetics or pathologic
features in the bladder can be directly tested in mice using our
Gardnerella exposure model.
In addition to the connection to UTI, the genes and biological
pathways affected by Gardnerella in our mouse model are related
to bladder function and intersect with a wide range of other
urological conditions, including but not limited to bladder
cancer, urinary incontinence, bladder pain syndrome and
interstitial cystitis. For example, cholinergic and bradykinin
receptors and the neuropeptide neruotensin (Nts) mediate
bladder muscle cell contraction (Dong et al., 2015; Dalghi
et al., 2020; Borsodi et al., 2021). Type 1 bradykinin receptors
like Bdkrb1 are generally not expressed in healthy tissue but are
induced by inﬂammatory mediators and injury (Marceau et al.,
1997), which is consistent with the increase in expression after
Gardnerella exposure. The nicotinic cholinergic receptor that
was induced by Gardnerella, Chrnb4, is expressed by bladder
afferent neurons and is necessary for strips of bladder tissue to
contract in response to nicotine stimulation ex vivo (Xu et al.,
1999). The Human Phenotype Ontology database reports that
the orphan nuclear receptor Nr4a2 is associated with bladder
function and urinary urgency. Dysregulation of the “neuroactive
ligand–receptor interaction” and “phototransduction” KEGG
pathways further suggests an inﬂuence of Gardnerella
exposures on the bladder–brain axis. The observation that
Gardnerella exposure induced genes related to bladder
sensation and urination is noteworthy because some studies in
women have detected an association between the presence of
Gardnerella in urine and urgency urinary incontinence. Future
studies could expand the exposure model to investigate the effect
of Gardnerella on urination frequency and other measures of
bladder function.
In summary, here, we demonstrate that Gardnerella directly
impacts the bladder, activating transcriptional inﬂammatory

seq dataset were urothelial integrity and inﬂammation, which are
known to be key host determinants of UPEC UTI. In summary,
the convergence of data from clinical studies and our Gardnerella
bladder exposure model led us to extend our model to examine
the effects of Gardnerella exposure on outcomes of UTIs caused
by UPEC. Data from this model provide evidence that
preexposures to Gardnerella can enhance UPEC acute and
persistent UTIs. Gardnerella preexposures enhanced UPEC
bacteriuria, at an early time point, in a manner dependent on
UPEC dose. The effect of Gardnerella on acute UPEC bacteriuria
was only evident when mice were given a relatively lower UPEC
inoculum. This observation suggests that Gardnerella bladder
exposures could lower the threshold dose required for UPEC to
establish UTI in women. Additionally, preexposure to
Gardnerella rendered mice more susceptible to persistent
UPEC bacteriuria and increased UPEC burden in bladder
tissue. The increase in bladder UPEC was detected even in
mice without persistent UPEC bacteriuria. The presence of
UPEC in bladder tissue in the absence of bacteriuria has
previously been attributed to stable UPEC reservoirs within
urothelial cells that can later emerge to cause a recurrent UTI
(Mulvey et al.). The data presented here warrant future studies
using established assays (e.g., immunoﬂuorescence microscopy,
gentamicin protection) to examine UPEC intracellular niche
distribution in the context of Gardnerella exposure. Taken
together, these data demonstrate that bladder exposures to
Gardnerella enhance UPEC UTI in a relevant in vivo model
and provide further biological explanation for the association
between BV and UTI observed in women.
While it is evident from the data presented here that
Gardnerella exposures enhance UPEC UTI, the molecular
mechanisms driving this effect remain to be determined.
Despite Gardnerella activating transcription of inﬂammatory
pathways, we observed no evidence of tissue inﬂammation.
However, it remains possible that distinct immune cell
populations are responding to Gardnerella in ways that require
more focused assays to detect. So far, the data point to the effect
of Gardnerella on the urothelium as the most likely source of
inﬂuence on UPEC UTI. Future experiments could test this idea
by attempting to block exfoliation using cell-death pathway
inhibitors. Prior studies have pointed to host responses
happening during the acute stages of UPEC infection as
drivers of chronic outcomes (Hannan et al., 2010; Schwartz
et al., 2015). We expect that a similar situation is occurring in
our preexposure model, meaning that whatever is promoting
UPEC persistence in Gardnerella-exposed mice occurs during
the early stages of UPEC infection. We do not expect that
Gardnerella directly impacts the bladder tissue 1 month after
exposure because Gardnerella is cleared from the mouse urinary
tract by 12 h (Gilbert et al.).
A limitation of our study was that we only examined a single
time point. Also, since we examined bladders 12 h after two
exposures to Gardnerella, we cannot distinguish whether the
differences required two exposures or if they would have
occurred 24 h following one exposure. Since whole bladders
were analyzed, we cannot attribute transcriptional changes to
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responses and causing urothelial exfoliation and turnover. We
present further evidence of Gardnerella as a “covert pathogen” in
the bladder (Gilbert and Lewis, 2019), affecting outcomes of
UPEC UTI at time points long after Gardnerella has been cleared
from the bladder. These ﬁndings have important implications for
how we think about the potential inﬂuence of urobiome bacteria
on disease outcomes in the bladder.

Bioanalyzer RIN score >8.0 obtained for all samples. ds-cDNA
was prepared using the SMARTer Ultra Low RNA Kit for
Illumina Sequencing (Takara-Clontech) per the manufacturer’s
protocol. cDNA was fragmented using a Covaris E220 sonicator
using peak incident power of 18, duty factor 20%, cycles/burst 50,
time 120 s to yield an average size of 200 base pairs (bp). cDNA
was then blunt ended, had an A base added to the 3′ ends, and
then had Illumina sequencing adapters ligated to the ends.
Ligated fragments were then ampliﬁed for 12 cycles using
primers incorporating unique index tags. Fragments were
multiplexed with 5–6 samples per lane and were sequenced on
an Illumina HiSeq 2500 using single-end 50 bp reads to target
30 M reads per sample.

MATERIALS AND METHODS
Ethics Statement
Mouse experiments were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals. The Institutional Animal Care and Use
Committee (IACUC) of Washington University School of
Medicine approved all procedures in advance (Protocol
Numbers: 20170081 and 20-0031).

RNA-seq Data Acquisition, Quality Control,
and Processing
RNA-seq reads from the nine individual libraries were
demultiplexed using a custom demultiplexing script written in
Python and then aligned to the Ensembl GRCm38.76 (Mus
musculus) assembly with STAR version 2.0.4b. Subread:
featureCount version 1.4.5 was used to derive gene counts
from the number of uniquely aligned unambiguous reads.
Sailﬁsh version 0.6.3 was used to produce transcript counts.
RSeQC version 2.3 was used to assess sequencing performance
for total number of aligned reads, total number of uniquely
aligned reads, genes and transcripts detected, ribosomal fraction,
known junction saturation, and read distribution over known
gene models. All gene-level and transcript counts were then
imported into the R/Bioconductor package EdgeR and TMMnormalized to adjust for differences in library size. Genes or
transcripts not expressed in any sample were excluded from
further analysis. Spearman correlation matrix and
multidimensional scaling plots were used to assess the
performance of the samples. Generalized linear models with
robust dispersion estimates were created to test for gene/
transcript level differential expression. The ﬁts of the trended
and tagwise dispersion estimates were then plotted to conﬁrm
proper ﬁt of the observed mean to variance relationship where
the tagwise dispersions are equivalent to the biological
coefﬁcients of variation of each gene. Differentially expressed
genes and transcripts (comparing PBS vs. Gardnerella) were then
ﬁltered for FDR-adjusted p-values less than or equal to 0.05.
Global perturbations in known GO terms and KEGG pathways
were detected for each EdgeR contrast using the R/Bioconductor
package GAGE to test for changes in expression of the reported
log2 fold-changes reported by edgeR in each term versus the
background log2 fold-changes of all genes found outside the
respective term.

Bacterial Strains and Growth Conditions
Gardnerella strain JCP8151B (Lewis et al., 2013) was grown
anaerobically at 37°C in static liquid culture in NYCIII medium
for 16 h or on NYCIII agar plates with 1 mg/ml streptomycin.
Uropathogenic E. coli strain UTI89, harboring a kanamycin
resistance cassette (Wright et al., 2005), was grown aerobically
at 37°C in static liquid culture in Lysogeny Broth (LB) medium
for 18 h and subcultured 1:1,000 in fresh LB for 18 h or on LB
agar plates with 25 mg/ml kanamycin. Mouse inocula were
prepared as previously described (O'Brien et al., 2020).

Mice
Six- to seven-week-old female C57BL/6 mice were obtained from
Charles River (Fredericks facility). Mice were given a regular
chow diet in a speciﬁc pathogen-free facility with a 12-h light/12h dark cycle at Washington University School of Medicine. Mice
were allowed to acclimate to the facility after transport for 1 week
prior to experiments.

Mouse Urinary Tract Inoculation
Experiments for RNA-seq
Experiments were performed essentially as described previously
(O'Brien et al., 2020). Brieﬂy, mice were anesthetized with
isoﬂurane and then inoculated transurethrally with 50 ml
prepared inoculum of 1 × 10 8 CFU Gardnerella strain
JCP8151B (5 mice) or PBS (4 mice). Twelve hours later, mice
received a second transurethral inoculation of Gardnerella or
PBS. Twelve hours later, all mice were humanely sacriﬁced by
cervical dislocation under isoﬂurane anesthesia, and bladders
were aseptically harvested and ﬂash frozen in liquid nitrogen for
future RNA isolation.

Deparafﬁnization and Antigen Retrieval
Additional bladders were collected and ﬁxed overnight in 4%
paraformaldehyde at 4°C with gentle shaking and then
transferred to 70% ethanol. Bladders were embedded in
parafﬁn and sagittal sections were prepared and mounted on
glass slides. Slides were placed onto glass holding trays and then
placed into fresh Histo-Clear® Histological Clearing Agent,

Library Preparation and Sequencing
Bladders were homogenized and RNA was extracted using the
RNeasy Plus Mini kit (Qiagen). Libraries were prepared from
each bladder individually with 10 ng of total RNA, and RNA
integrity was determined using an Agilent Bioanalyzer, with a
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National Diagnostics, for 10 min two times. The trays were
drained, then moved to 100% ethyl alcohol for 10 min two times,
and then to 95% ethyl alcohol two times for 10 min. Finally, glass
trays holding the slides were placed under running water for
10 min. During the deparafﬁnization, fresh pH 9 and 6 buffered
antigen retrieval solutions were made and brought to a boil in
50 ml BD conical tubes in a glass beaker ﬁlled with water in a
steamer. After washing, glass slides were placed into the
appropriate buffer around 90°C–100°C without allowing the
slides to dry out and boiled for 15 and 30 min in for pH 9 and
pH 6 buffer, respectively. Slides were then cooled and allowed to
cool to 60°C and were washed in 0.5% Triton X-100 in
phosphate-buffered saline (PBS) at room temperature.

nonadjacent sections counted from each bladder. Cells at the
luminal interface were enumerated as CK20+ or CK20− in 1–2
images from each bladder section (>275 total cells counted per
group). The analysis of Ki67 staining used 3 mice per
experimental group, with two nonadjacent sections counted
from each bladder. Superﬁcial (C20+P63−) and intermediate
cells (P63+Krt5−) were enumerated as Ki67+ or Ki67− in 3–5
images from each bladder section (>2,000 total cells counted per
group). Bright-ﬁeld images were collected using a Nikon Eclipse
TE200 microscope. Data were analyzed using the Fiji package
of ImageJ.

Scanning Electron Microscopy
B l a d d e r s w e r e ﬁ xed in situ wi th EM ﬁx a tiv e (2%
paraformaldehyde, 2% glutaraldehyde in 0.1 M sodium
phosphate buffer, pH 7.4) as previously described (O'Brien
et al., 2020). Samples were postﬁxed in 1.0% osmium tetroxide,
dehydrated in increasing concentrations of ethanol, and then
dehydrated at 31.1°C and 1,072 PSI for 16 min in a critical point
dryer. Bladders were quadrisected to reveal the urothelial surface
and were mounted on carbon tape-coated stubs and sputtercoated with gold/palladium under argon. Bladders were imaged
on a Zeiss Crossbeam 540 FIB-SEM.

Antibody and Histology Staining
For histological analysis, slides were stained with hematoxylin
and eosin (H&E) according to standard protocol. For
immunostaining, glass slides were removed from wash buffer
one at a time, placed horizontally into humidiﬁed slide boxes,
and the hydrophobic boundary was marked around the
perimeter with a PAP PEN. About 300 ml of 10% heatinactivated horse serum (HIHS) and 3% bovine serum albumin
(BSA) in 0.5% Triton X-100 PBS were placed onto each slide for
blocking. Slides were incubated in a closed, humidiﬁed slide box
for 1 to 2 h. During blocking, primary antibody cocktails of
chicken anti-KRT 5 1:500; goat anti-P63 1:300; mouse anticytokeratin 20 1:200 or rabbit anti-Krt6a 1:1,500; rabbit antiKi67 1:200; and mouse anti-Upk3 1:50 were prepared in 1%
HIHS and 1% BSA in 0.5% Triton X-100 sufﬁcient for around
300 ml per slide. The blocking solution was removed by vacuum
and the primary antibody added onto the slide without
disturbing hydrophobic perimeter. Slides were incubated
overnight in humidiﬁed slide boxes at 4°C.
The following day, the primary antibody was removed, and
the slides were washed for 10 min in fresh 0.5% Triton X-100
PBS twice. During washes, secondary antibody cocktails were
prepared in1% HIHS and 1% BSA in 0.5% Triton X-100 for
300 ml per slide, and two drops of NucBlue® nuclear staining
reagent (DAPI) were added per milliliter of antibody cocktail.
Slides were removed from the washing buffer and hydrophobic
perimeters redrawn then a secondary antibody cocktail was
added. Slides were incubated in the dark at room temperature
for 30 min to 1 h. After incubation, slides were washed, and
previously warmed DAKO glycerol mounting medium was
applied before the coverslip. Slides were stored overnight at 4C
in slide folders.

Mouse Model Examining the Effects of
Gardnerella “Preexposures” on UPEC UTI
Mice were anesthetized with isoﬂurane and then inoculated
intravesically twice, 12 h apart, with either 50 ml of prepared
1 × 108 Gardnerella strain JCP8151B inoculum or PBS as a
control, as described above. Twelve hours after the second
inoculation, mice were inoculated with 50 ml of prepared
inoculum containing either 1 × 107 or 1 × 106 UPEC strain
UTI89kanR. To monitor acute UPEC infection, urine was
collected at 6 and 24 h after UPEC inoculation, and titers were
enumerated by serial dilution and plating on LB + kanamycin
selective media. A subset of mice was monitored for UPEC
persistence in the urinary tract by enumerating UPEC in urine
weekly out to 4 weeks postinfection. At 4 wpi, mice were
humanely sacriﬁced by cervical dislocation under isoﬂurane
anesthesia, and bladders were aseptically harvested.
Homogenates were prepared in 1 ml of sterile PBS and plated
on selective media. Samples with no colonies were plotted at the
limit of detection.

Cytokine and Chemokine Analysis
Cytokine content was measured in mouse serum using the BioPlex-Pro Mouse Cytokine 23-Plex, Group I Panel Multiplex
Cytokine Bead Kit (Bio-Rad), which quantiﬁes the following 23
cytokines and chemokines: IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5,
IL-6, IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL-17A, Eotaxin, GCSF, GM-CSF, IFN-g, KC, MCP-1, MIP-1a, MIP-1b, RANTES,
and TNF-a. The assay was performed according to manufacturer
instructions, except using a tenfold less standard and half the
amount of coupled beads and detection antibodies indicated in
the protocol.

Immunoﬂuorescent and Brightﬁeld
Imaging and Analysis
Fluorescent images were acquired with a Zeiss Axiovert 200M
microscope with Zeiss Apotome as previously described (Tate
et al., 2021). Urothelium cell types were distinguished and
counted as: basal cells Krt5+P63+, intermediate cells P63
+Krt5−, and superﬁcial cells were P63−CK20+. The analysis of
CK20 staining used 2 mice per experimental group, with three
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The animal study was reviewed and approved by the Institutional
Animal Care and Use Committee (IACUC) of Washington
University School of Medicine.
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